Seroflo 500 Ciphaler
Generic: Salmeterol/Fluticasoneby Cipla Limited

Similar medicines
View allAbout Seroflo 500 Ciphaler
Seroflo 500 Ciphaler is a salmeterol and fluticasone inhaler made in India by Cipla, sold under its Ciphaler device name (Cipla's Ciphaler products in the UK and Australia are dry powder inhalers). Indian pharmacy listings give each dose as salmeterol 50 mcg, a long-acting bronchodilator (LABA), and fluticasone propionate 500 mcg, an inhaled corticosteroid, with 60 doses per inhaler (Tata 1mg, Medkart). It is a twice-daily preventer for asthma and, in some countries' labels, for COPD. 500 mcg is the highest fluticasone strength of this combination: the US label sets it as the maximum asthma dose. We sell packs of 1, 2 and 3 inhalers, from $38.33 an inhaler in the 3 pack.
This page covers who the 500 strength is for, how US and UK labels differ on COPD, how to use the Ciphaler, the pneumonia and adrenal risks that come with a high steroid dose, when to get urgent help, who should not use it and the price per inhaler. Clinical figures come from the US prescribing information for Advair Diskus (GSK) and the UK product information for Seretide 500 Accuhaler (GSK) and Sereflo Ciphaler 50/500 (Cipla EU), listed at the end. We have not found a published study comparing the Indian Seroflo Ciphaler with Advair Diskus.
Seroflo is not a reliever. The US label says it is "NOT indicated for the relief of acute bronchospasm", and the UK label says it "should not be used to treat acute asthma symptoms for which a fast- and short- acting bronchodilator is required". Keep a fast-acting reliever, such as salbutamol, with you at all times.
Seroflo 500 Ciphaler at a glance
| Active ingredients | Salmeterol 50 mcg (as xinafoate) and fluticasone propionate 500 mcg per dose, as listed by Indian pharmacies |
| Brand and maker | Seroflo, by Cipla Limited, India (Tata 1mg, Medkart) |
| Device | Ciphaler, 60 doses. Cipla's UK and Australian Ciphaler products are dry powder inhalers with a 60-blister strip; some Indian listings call the Indian pack an "MDI", which conflicts with this (see below). |
| Used for | Regular (maintenance) treatment of asthma in people aged 12 and over; COPD in the UK and Australian labels, but not at this strength in the US label |
| Regulatory status | Salmeterol with fluticasone propionate 50/500 is licensed in the US (Advair Diskus 500/50 and generics), the UK (Seretide 500 Accuhaler, and Cipla's own Sereflo Ciphaler 50/500), Australia (Seretide Accuhaler 500/50, and Cipla's Fluticasone Salmeterol Ciphaler 500/50) and Canada (Advair 500 Diskus). This Indian Seroflo pack is not registered with the FDA, MHRA, TGA or Health Canada. |
| Usual dose from the labels | 1 inhalation twice a day, about 12 hours apart (US label 2.1; UK label 4.2). The US label says not to take more. |
| Timing | US label: asthma control can improve within 30 minutes of starting, but maximum benefit may take 1 week or longer |
| Packs | 1, 2 and 3 inhalers (one inhaler is 30 days at the labelled dose, our arithmetic) |
| Price per inhaler | $40.00 (1 inhaler) down to $38.33 (3 pack), before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
Price per inhaler
Prices below are as of October 2026. The pack selector above always shows the current price.
| Pack | Price | Per inhaler | Shipping | Per inhaler with shipping | Lasts at 1 inhalation twice a day |
|---|---|---|---|---|---|
| 1 inhaler | $40 | $40.00 | $25 | $65.00 | 30 days |
| 2 inhalers | $78 | $39.00 | $25 | $51.50 | 60 days |
| 3 inhalers | $115 | $38.33 | $25 | $46.67 | 90 days |
The last column is our arithmetic: 60 doses at 1 inhalation twice a day is 30 days, if every dose is used before the opened inhaler's discard date. All three packs are under the $149 free shipping threshold, so the flat $25 adds most to a single inhaler. The 3 pack is the cheapest per inhaler before and after shipping. The smallest order that reaches free shipping is a 3 pack plus a 1 pack ($155 for 4 inhalers, $38.75 each, our arithmetic). Do not buy more than your prescription covers, and check the expiry date when your order arrives.
Compared with Advair Diskus and US generics
| Seroflo 500 Ciphaler | Advair Diskus 500/50 (US) | US generic fluticasone and salmeterol 500/50 powder | |
|---|---|---|---|
| Maker | Cipla, India | GSK | Several, including Wixela Inhub (Mylan) and Cipla USA |
| Dose per inhalation | Salmeterol 50 mcg, fluticasone propionate 500 mcg (Indian listings) | Salmeterol 50 mcg, fluticasone propionate 500 mcg per blister | Salmeterol 50 mcg, fluticasone propionate 500 mcg |
| Doses per inhaler | 60 | 60 | 60 |
| FDA approved | No | Yes | Yes |
| Price per inhaler (ours) or US pharmacy cost | $38.33 to $40.00 before shipping; $46.67 to $65.00 with shipping | About $253.64 pharmacy acquisition cost (NADAC) | About $97.48 pharmacy acquisition cost (NADAC) |
NADAC is what US pharmacies pay, not a retail price. The NADAC rates effective 21 October 2026 are $4.22734 per blister for Advair Diskus 500/50 and $1.62461 per blister for each generic 500/50 row (Wixela Inhub and three other generic NDCs); the per-inhaler figures are those rates times 60 blisters (our arithmetic). Our price is lower than the US generic acquisition cost, but if you are in the US and have insurance or a prescription, compare your copay and local cash prices for the generic before you order an unregistered product from abroad.
In Great Britain, Cipla EU holds a licence for Sereflo Ciphaler 50/500 (PLGB 36390/0296), and in Australia Cipla's Fluticasone Salmeterol Ciphaler 500/50 is a Schedule 4 PBS medicine. Those packs are made for those markets; we sell the Indian Seroflo pack, and we have not seen evidence that it is the same product as the UK or Australian pack, so do not treat it as a registered medicine there.
Which strength to choose
The fluticasone number is what changes between strengths; the salmeterol dose stays at 50 mcg per inhalation (or 25 mcg per puff of the sprays, taken as 2 puffs). Daily totals are our arithmetic from the labelled doses.
| Product | Per dose | Labelled adult use | Fluticasone a day | Where it sits in the labels |
|---|---|---|---|---|
| Seroflo 250 Ciphaler | 250 mcg / 50 mcg, 60 doses (Truemeds) | 1 inhalation twice a day | 500 mcg | Matches Advair Diskus 250/50, the only US COPD dose |
| Seroflo 500 Ciphaler (this page) | 500 mcg / 50 mcg | 1 inhalation twice a day | 1,000 mcg | US: the maximum asthma dose, age 12 and over. UK and Australia: asthma (12 and over) and COPD |
| Seroflo 500 Rotacaps | 500 mcg / 50 mcg per capsule, 30 capsules (Truemeds) | 1 capsule twice a day in a separate capsule inhaler device | 1,000 mcg | Same strength in capsules for a separate device |
| Seroflo 250 Inhaler | Listed as 250 mcg / 25 mcg, 120 doses (PharmEasy) | 2 puffs twice a day | 1,000 mcg | Same daily total as a spray; the US match is Advair HFA 230/21 |
| Seroflo Synchrobreathe Inhaler 250 | Listed as 250 mcg / 25 mcg, 120 doses (PharmEasy) | 2 puffs twice a day | 1,000 mcg | Breath-actuated spray for people who struggle to press and breathe in together |
The US label says to choose the starting strength from the person's asthma severity, earlier treatment and current control, and that if a starting dose has not worked after 2 weeks a higher strength "may provide additional improvement". The UK label says the dose "should be titrated to the lowest dose at which effective control of symptoms is maintained", that Seretide "is not intended for the initial management of mild asthma" and that "In general inhaled corticosteroids remain the first line treatment for most patients". Our reading: Seroflo 500 is usually a step for asthma that a lower dose has not controlled, set by a doctor, and not a strength to move to on your own. Lower strengths (100/50 and 250/50) exist for when asthma is controlled and the dose can come down.
COPD: the US and UK labels differ on this strength
- US label: Advair Diskus 250/50 twice daily "is the only approved dosage for the treatment of COPD because an efficacy advantage of the higher strength ADVAIR DISKUS 500/50 over ADVAIR DISKUS 250/50 has not been demonstrated" (1.2). Across trials, the fall in exacerbations with 500/50 "was not greater than" with 250/50 (14.2).
- UK label: 50/500 twice daily is the COPD dose, for "patients with COPD, with a FEV1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy" (Seretide and Sereflo Ciphaler 4.1, 4.2).
- Australia: the registered indication covers severe COPD (FEV1 below 50% predicted) with repeated exacerbations and significant symptoms despite regular beta-2 agonist bronchodilator therapy, and says it is not for starting bronchodilator therapy in COPD (healthdirect, from the ARTG).
Which strength suits your COPD is a decision for your doctor. If you are in the US with COPD, Seroflo 500 is not the US labelled COPD dose. Pneumonia is more common with inhaled steroids in COPD (see side effects).
A LABA must never be used alone for asthma
The US label says use of a LABA as monotherapy (without an inhaled steroid) for asthma "is associated with an increased risk of asthma-related death". In the SMART trial, salmeterol added to usual therapy without a required inhaled steroid gave 13 asthma deaths in 13,176 people against 3 in 13,179 on placebo. Seroflo contains both medicines in each dose, which meets the rule. In four large 26-week safety trials, steroid plus LABA combination inhalers did not show a significant increase in serious asthma-related events against the steroid alone, although the label says the trials "were not designed to rule out all risk" (US 5.1).
Two practical rules follow from the label. Do not use another LABA-containing inhaler at the same time: the US label says people using Advair Diskus "should not use another medicine containing a LABA (e.g., salmeterol, formoterol fumarate, arformoterol tartrate, indacaterol) for any reason" (5.3). In our range that rules out combining it with, for example, Foracort 200 (budesonide with formoterol). And never take more than 1 inhalation twice a day: the label says excessive use of inhaled sympathomimetic drugs has been linked with clinically significant heart effects and deaths.
How to use the Seroflo Ciphaler
These steps follow the UK label for Cipla's Sereflo Ciphaler 50/500. Follow the Cipla leaflet in your pack as well.
- Hold the inhaler in one hand and push the thumb grip away as far as it goes, until it clicks, to open the mouthpiece.
- With the mouthpiece towards you, slide the lever away as far as it goes, until it clicks. This loads one dose. Do not play with the lever: each pull opens a blister and wastes a dose.
- Holding the inhaler away from your mouth, breathe out as far as is comfortable. Do not breathe into the mouthpiece.
- Put the mouthpiece to your lips and breathe in steadily and deeply through the inhaler, not through your nose.
- Take the inhaler out of your mouth, hold your breath for about 10 seconds or as long as is comfortable, then breathe out slowly.
- Rinse your mouth with water and spit it out. The US label says to rinse "without swallowing" to help reduce the risk of thrush in the mouth and throat; the UK label says this may also help prevent hoarseness.
- Slide the thumb grip back until it clicks to close the inhaler. The counter shows the doses left; the UK label says the numbers 5 to 0 turn red, and at 0 the inhaler is empty. Wipe the mouthpiece with a dry tissue to clean it.
Take it every day, about 12 hours apart, even when you feel well. The UK label says treatment "should not be stopped abruptly in patients with asthma due to risk of exacerbation"; any step down should be supervised by a doctor. If you were using a short-acting reliever regularly (for example 4 times a day), the US label says regular use should stop when this treatment starts, and the reliever kept for symptoms.
Device and pack questions. Tata 1mg lists the pack as "60 MDI Inhaler" and Medkart as "60 MD", and their how-to text describes other inhaler types (Medkart describes pressing a canister; the Tata 1mg FAQ calls it a breath-actuated inhaler). Cipla's UK Sereflo Ciphaler is a dry powder inhaler with a 60-blister strip and a dose counter. If your carton shows a pressurised spray instead, follow that leaflet and ask us before use.
Storage: the UK Sereflo Ciphaler label says no special storage conditions, "Do not refrigerate or freeze", do not store the opened product above 25°C, and use within 2 months of opening the foil pouch. The US Advair Diskus label says keep it in the unopened foil pouch until first use and discard it 1 month after opening the pouch or when the counter reads 0, whichever comes first. The Australian Cipla Ciphaler is stored below 25°C. Indian listings say store below 30°C (Tata 1mg) or at room temperature (Medkart). Follow the discard period printed on your Indian carton; if it gives none, the shorter US rule (1 month after opening) is our cautious suggestion. Our parcels are not temperature controlled.
Lactose: the UK Sereflo Ciphaler contains up to 11.3 mg of lactose per delivered dose, and the label says lactose "contains small amounts of milk proteins, which may cause allergic reactions". The Indian listings we checked do not name the excipients; read the carton.
Groups who need extra care
- Children under 12: Seroflo 500 Ciphaler is not suitable. The US label gives 500/50 only to people aged 12 and over (children aged 4 to 11 use 100/50), and the UK Sereflo Ciphaler label says it is "not recommended in children below 12 years of age due to lack of data on safety and efficacy". The UK label also says children and adolescents under 16 taking high doses of fluticasone propionate (typically 1000 micrograms a day or more; this strength at the labelled dose gives 1000 micrograms a day, our arithmetic) "may be at particular risk" of systemic effects, and recommends regular height checks.
- Coming off steroid tablets: the US label says deaths due to adrenal insufficiency have occurred in people with asthma during and after transfer from steroid tablets to inhaled steroids, and recovery of adrenal function takes a number of months. People who took 20 mg or more of prednisone a day may be most at risk. Tablets should be reduced slowly (the label gives 2.5 mg a week as an example) under supervision, and people should carry a warning card.
- High dose, long periods: the UK label says prolonged high doses may cause adrenal suppression and acute adrenal crisis, and that "Very rare cases of adrenal suppression and acute adrenal crisis have also been described with doses of fluticasone propionate between 500 and less than 1000 micrograms". Triggers include trauma, surgery, infection or a rapid dose cut; extra steroid cover should be considered during stress or planned surgery.
- COPD: pneumonia risk (see side effects). The US label recommends a bone density check before starting in COPD and periodically after.
- Heart disease (especially coronary insufficiency, arrhythmias and high blood pressure), seizure disorders or an overactive thyroid: use with caution (US 5.12, 5.17). The UK label adds diabetes, uncorrected low potassium and people predisposed to low potassium. Large doses of salmeterol (12 to 20 times the recommended dose) have been linked with QTc prolongation (US 5.12).
- Liver disease: both medicines are cleared by the liver, so the US label says people with liver disease "should be closely monitored"; the UK label has no data.
- Weak bones, cataracts or glaucoma: the US label says people with major risk factors for low bone density should be monitored, and to consider referral to an eye specialist for anyone with eye symptoms or on long-term use. The UK label says blurred vision or other visual disturbance should prompt consideration of referral.
- Older people and kidney problems: the UK label says no dose change is needed. The US label says older people with COPD had more serious adverse events and more pneumonia.
- Pregnancy: the UK label says data from more than 1000 pregnancy outcomes indicate no malformative or feto/neonatal toxicity, and use "should only be considered if the expected benefit to the mother is greater than any possible risk to the fetus", at the lowest effective fluticasone dose. The US label says poorly controlled asthma raises risks such as pre-eclampsia and prematurity, and that use during labour should be restricted to those in whom the benefits clearly outweigh the risks.
- Breastfeeding: the UK label says a risk to the breastfed infant cannot be excluded and a decision must be made whether to stop breastfeeding or the medicine. The US label says there are no human data, and levels in milk are likely to be low.
Medicines that interact:
- Ritonavir and other strong CYP3A4 inhibitors: the US label says the use of strong CYP3A4 inhibitors (for example ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, ketoconazole, telithromycin) "is not recommended because increased systemic corticosteroid and increased cardiovascular adverse effects may occur". The UK label says ritonavir "can greatly increase the concentration of fluticasone propionate in plasma" and should be avoided "unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects"; it names itraconazole and cobicistat-containing products as other potent inhibitors to avoid on the same basis. Cushing's syndrome and adrenal suppression have been reported with ritonavir.
- Ketoconazole: in a US label study it raised salmeterol exposure (AUC) 16-fold, and 3 of 20 healthy people withdrew with beta agonist side effects, 2 of them with a prolonged QTc. With fluticasone it gave a 1.9-fold rise in exposure.
- Beta blockers, including cardioselective ones: the US label says people with asthma or COPD "should not normally be treated with beta-blockers"; the UK label says they "should be avoided unless there are compelling reasons for their use".
- MAO inhibitors and tricyclic antidepressants, including within 2 weeks of stopping them: "extreme caution" (US 7.2).
- Loop or thiazide diuretics: caution, because of low potassium and ECG changes (US 7.4).
Side effects
The UK Seretide Accuhaler label lists these by frequency for salmeterol with fluticasone (section 4.8). This table gives every item in that list:
| How often (UK label) | Side effect |
|---|---|
| Very common (1 in 10 or more) | Headache; nose and throat infection (nasopharyngitis) |
| Common (1 in 100 to under 1 in 10) | Thrush in the mouth and throat; pneumonia (in people with COPD); bronchitis; low potassium; throat irritation; hoarseness; sinusitis; bruising; muscle cramps; traumatic fractures; joint pain; muscle pain |
| Uncommon (1 in 1,000 to under 1 in 100) | Allergic skin reactions; breathlessness as an allergy sign; anxiety; sleep problems; raised blood sugar; tremor; cataract; palpitations; fast heartbeat; atrial fibrillation; angina |
| Rare (1 in 10,000 to under 1 in 1,000) | Thrush of the oesophagus; angioedema; bronchospasm and anaphylaxis as allergy signs; Cushing's syndrome, adrenal suppression, slowed growth in children and adolescents, lower bone density; glaucoma; heart rhythm problems; behaviour changes mainly in children; wheezing straight after a dose (paradoxical bronchospasm) |
| Not known | Depression and aggression (mainly in children); blurred vision |
Source: UK label 4.8; several items were also reported commonly with placebo, which the label marks. The US asthma side effect table (Table 2) has no 500/50 column; the label says side effects in a 28-week trial of 500/50 "were similar".
Pneumonia in COPD. The 500/50 strength was tested in a 3-year US-label trial in 6,184 adults with COPD:
| Group | Advair Diskus 500/50 | Fluticasone propionate 500 mcg | Salmeterol 50 mcg | Placebo |
|---|---|---|---|---|
| Pneumonia reported, all ages | 16% | 14% | 11% | 9% |
| Older than 65 | 18% | 10% | ||
| Younger than 65 | 14% | 8% | ||
| Events per 1,000 treatment-years | 88 | 84 | 52 | 52 |
Source: US label 5.5 and 6.2. Blank cells are not given in the label. The UK label reports the same 3-year trial as an estimated pneumonia probability of 19.6% with Seretide against 12.3% with placebo, with "no increase in pneumonia related deaths" (5.1), and lists current smoking, older age, low body mass index and severe COPD as risk factors (4.4). In the same trial, survival "was not significantly improved" against placebo (all-cause mortality 12.6% vs 15.2%), and moderate and severe exacerbations fell by 25.1% against placebo (US 14.2). The US label tells people with COPD to contact their doctor if they develop symptoms of pneumonia; the signs of pneumonia and of a COPD flare often overlap.
Other label items: rinsing the mouth after each dose helps with thrush and hoarseness, and thrush can be treated with an antifungal while carrying on (US 5.4, UK 4.8). Beta agonist effects such as tremor, palpitations and headache "tend to be transient and reduce with regular therapy" (UK 4.8). Rarely, people on inhaled fluticasone have had eosinophilic conditions with vasculitis consistent with Churg-Strauss syndrome, usually after oral steroids were reduced (US 5.16).
When to get urgent help
- A severe asthma or COPD attack, or one that your reliever does not help: call emergency services now (911 in the US and Canada, 999 in the UK, 000 in Australia; this is our advice). Seroflo will not relieve an attack, and extra doses should not be used for that purpose (US 5.2). The UK label says "Sudden and progressive deterioration in control of asthma is potentially life-threatening and the patient should undergo urgent medical assessment".
- Wheezing or breathlessness that gets worse straight after a dose (paradoxical bronchospasm): use your fast-acting reliever now and stop Seroflo. The US label says this "may be life threatening", should be treated immediately and the inhaler stopped immediately. Stridor or choking (throat swelling or spasm) has also been reported (US 5.10).
- Hives, swelling of the face, lips, tongue or throat, rash, wheezing or feeling faint: signs of an allergic reaction, including anaphylaxis. The US label says stop the inhaler if this happens. People with a severe milk protein allergy have had anaphylactic reactions to lactose-containing powder inhalers.
- Vague illness such as loss of appetite, tummy pain, weight loss, tiredness, headache, nausea or vomiting, low blood pressure, drowsiness or reduced consciousness, low blood sugar or a fit, especially during an infection, after surgery or after a dose cut: the UK label lists these as signs of acute adrenal crisis. If the person is drowsy or confused, has a fit, or keeps vomiting, call emergency services now; otherwise get medical help the same day and tell the doctor about the steroid (our advice).
- Chest pain, a very fast or irregular heartbeat, or a seizure: the US label links excessive beta agonist stimulation with these.
- Taking far more than prescribed: the US label says "Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs"; overdose can prolong the QTc interval, and the label says that, as with all inhaled sympathomimetic medicines, cardiac arrest and even death may be associated with an overdose of salmeterol. Get medical advice straight away and tell staff what you took, how much and when.
- Your reliever works less well or you need it more often than usual: the US label says to seek medical attention immediately; increasing reliever use "is a marker of deteriorating asthma".
- Possible pneumonia if you have COPD, for example fever, chills, more sputum or a change in its colour, or worse cough or breathing (our examples): the US label says to contact your healthcare provider if symptoms of pneumonia develop.
- Exposure to chickenpox or measles if you have not had them or been properly immunised: the US label says these can have a more serious or even fatal course in people using corticosteroids. Contact a doctor without delay.
Who should not use Seroflo 500 Ciphaler
Never use it (contraindications):
- if you are allergic to salmeterol, fluticasone propionate or any ingredient of the inhaler (US label 4; UK label 4.3);
- if you have a severe milk protein allergy (US label 4; the US product contains lactose, which contains milk proteins);
- as the main treatment for status asthmaticus or another acute asthma or COPD episode that needs intensive measures (US label 4).
Should not use (label warnings):
- for relief of sudden symptoms, or started during a rapidly worsening or potentially life-threatening episode (US 5.2; UK 4.4 says not during an exacerbation or significantly worsening asthma);
- together with another LABA-containing medicine (US 5.3);
- children under 12 (see above);
- rare hereditary galactose intolerance, total lactase deficiency or glucose-galactose malabsorption: the UK Sereflo Ciphaler label says these patients "should not take this medicine" (it contains lactose).
Use with caution, if at all (US label 5.6): active or quiescent tuberculosis infections of the respiratory tract; systemic fungal, bacterial, viral or parasitic infections; herpes infection of the eye. The UK label says caution with active or quiescent lung tuberculosis and fungal, viral or other airway infections.
Not recommended or avoid unless the benefit outweighs the risk: strong CYP3A4 inhibitors such as ritonavir, cobicistat-containing products, itraconazole, ketoconazole and clarithromycin (see above).
Talk to a doctor first: heart disease, high blood pressure, seizures, an overactive thyroid, diabetes, low potassium, liver disease, weak bones, eye problems, COPD, pregnancy or breastfeeding; if you are coming off steroid tablets or planning surgery; if you take beta blockers, MAO inhibitors, tricyclic antidepressants or water tablets.
Prescription and legal status
Salmeterol with fluticasone propionate inhalers are prescription medicines in the US (Advair Diskus and its generics), the UK (emc lists Seretide 500 Accuhaler as a prescription only medicine), Australia (Schedule 4, on the PBS under item codes 14450M and 8432T, healthdirect) and Canada (Health Canada's Drug Product Database lists Advair 500 Diskus, DIN 02240837, as a marketed prescription product). Indian listings mark Seroflo 500 Ciphaler as "Prescription required" (Tata 1mg, Medkart). This Indian Seroflo pack is not registered with the FDA, the MHRA, the TGA or Health Canada, and in the US the FDA says personal importation of unapproved medicines is illegal in most circumstances. The UK label says patients "should be regularly reassessed by a doctor" so the strength stays right and is only changed on medical advice. Check the rules where you live.
Buying genuine Seroflo
The MHRA warns: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It also advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo." That warning covers this Indian Seroflo pack, even though Cipla's own Sereflo Ciphaler is licensed in the UK. When your order arrives, check that the carton and inhaler name Cipla, Seroflo 500 and salmeterol 50 mcg with fluticasone propionate 500 mcg, show a batch number and an expiry date, that the foil pouch is sealed, and that the counter starts at 60. These checks cannot prove an inhaler is genuine, because counterfeiters copy packaging. If your asthma or COPD control gets worse after switching supply, see a doctor rather than taking extra doses. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.
Delivery
We ship Seroflo 500 Ciphaler to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries, so order at least three weeks before your current inhaler runs out: a preventer works only if it is used every day, and the UK label warns against stopping abruptly. Shipping costs a flat $25 on orders under $149 and is free from $149. See our shipping page and refund policy.
Related guides
- Generic Advair and Seroflo: what the strength numbers mean
- Advair vs Symbicort (Seroflo vs Foracort): which combination inhaler
- Rotacaps vs inhaler vs respules: which device gets the dose into your lungs
- Prednisolone for asthma flare-ups: dose, course length and risks
- Breztri vs Trelegy: triple inhalers for COPD and asthma compared
Relievers: Asthalin Inhaler (salbutamol) and Levolin 0.63mg Respules (levosalbutamol). Other preventers: Foracort 200 Inhaler (budesonide with formoterol; not to be used with Seroflo) and Flohale 0.5 Respules (fluticasone alone, for a nebuliser). See also our asthma treatment overview.
Sources
- Advair Diskus (fluticasone propionate and salmeterol inhalation powder), GSK, US prescribing information, DailyMed setid 4eeb5f6a-593f-4a9e-9692-adefa2caf8fc, version 32, effective 26 March 2026, sections 1, 2, 4, 5.1 to 5.18, 6.1 to 6.3, 7, 8, 10, 11, 14.2, 16 and 17. DailyMed
- Fluticasone propionate and salmeterol inhalation powder, Cipla USA, US prescribing information, DailyMed setid 1349a04c-2024-42b9-b81d-a7d995716ade, version 1, section 16. DailyMed
- Wixela Inhub, Mylan, US prescribing information, DailyMed setid 3beef422-8a07-4a45-9ba6-414511e4b7e2, version 6, section 16. DailyMed
- Seretide 100, 250, 500 Accuhaler, GSK UK, summary of product characteristics, date of revision 3 August 2023, sections 2, 4.1 to 4.9, 5.1, 6.1 to 6.5. emc
- Sereflo Ciphaler 50 microgram / 500 microgram per dose inhalation powder, Cipla (EU) Limited, PLGB 36390/0296, summary of product characteristics, date of revision 1 April 2024, sections 2, 4.1, 4.2, 4.4, 6.1 to 6.5. emc
- healthdirect Australia: Seretide Accuhaler 500/50 and Fluticasone Salmeterol Ciphaler 500/50 (Cipla), ARTG and PBS data, accessed 21 October 2026. healthdirect
- Health Canada Drug Product Database: Advair 500 Diskus, DIN 02240837, searched 21 October 2026. Health Canada DPD
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), Advair 500-50 Diskus (NDC 00173069700) and generic fluticasone-salmeterol 500-50 and Wixela 500-50 Inhub (NDCs 00054032856, 00093751631, 66993058697, 00378932232), rates effective 21 October 2026. data.medicaid.gov
- Tata 1mg and Medkart. Seroflo 500 Ciphaler (Cipla) listings, accessed 21 October 2026. Tata 1mg
- Truemeds (Seroflo 500 Rotacap 30 and Seroflo 250 Ciphaler 60) and PharmEasy (Seroflo 250 Inhaler and Seroflo 250 Synchrobreathe Inhaler) Cipla listings, accessed 21 October 2026. PharmEasy
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is for information and is not medical advice. Salmeterol with fluticasone is a prescription medicine; your doctor should set your strength and your asthma or COPD action plan.
Frequently asked questions
What is Seroflo 500 Ciphaler?
Seroflo 500 Ciphaler is a salmeterol and fluticasone inhaler made in India by Cipla, sold under its Ciphaler device name (Cipla's Ciphaler products in the UK and Australia are dry powder inhalers). Indian listings give each dose as salmeterol 50 mcg, a long-acting bronchodilator, and fluticasone propionate 500 mcg, an inhaled corticosteroid, with 60 doses per inhaler (Tata 1mg, Medkart). It is a twice-daily preventer for asthma in people aged 12 and over and, in the UK and Australian labels, for COPD. It is not a reliever: keep a fast-acting reliever such as salbutamol for sudden symptoms.
Is Seroflo 500 Ciphaler the same as Advair Diskus 500/50?
It has the same labelled strength, salmeterol 50 mcg with fluticasone propionate 500 mcg per inhalation, 60 doses, but it is a different product from a different maker (Cipla in India, GSK in the US). We have not found a published study comparing them. Cipla's own Sereflo Ciphaler 50/500 is licensed in the UK and its Fluticasone Salmeterol Ciphaler 500/50 in Australia, but the Indian Seroflo pack we sell is not registered with the FDA, MHRA, TGA or Health Canada.
How much does Seroflo 500 Ciphaler cost per inhaler?
As of October 2026, $40.00 for 1 inhaler, $39.00 each in the 2 pack ($78) and $38.33 each in the 3 pack ($115), before shipping. Shipping is $25 under $149, so with shipping that is $65.00, $51.50 and $46.67 an inhaler. The pack selector shows the current price. For comparison, the US pharmacy acquisition cost (NADAC, effective 21 October 2026) works out at about $253.64 for an Advair Diskus 500/50 and about $97.48 for a generic 500/50 inhaler (our arithmetic); NADAC is not a retail price.
How do I use the Seroflo Ciphaler?
Following the UK Sereflo Ciphaler label: push the thumb grip until it clicks, slide the lever until it clicks to load a dose, breathe out away from the mouthpiece, then breathe in steadily and deeply through it. Hold your breath for about 10 seconds, breathe out slowly, rinse your mouth with water and spit it out, then close the inhaler. Take 1 inhalation twice a day, about 12 hours apart, every day. Do not play with the lever, as each pull wastes a dose.
How long does one Seroflo 500 Ciphaler last?
At the labelled dose of 1 inhalation twice a day, a 60-dose inhaler lasts 30 days (our arithmetic). Once the foil pouch is opened there is also a discard period: the UK Sereflo Ciphaler label says use within 2 months, and the US Advair Diskus label says discard 1 month after opening or when the counter reads 0, whichever comes first. Follow the period printed on your Indian carton.
How quickly does Seroflo 500 work?
The US Advair Diskus label says asthma control can improve within 30 minutes of starting treatment, but maximum benefit may not be reached for 1 week or longer, and people vary. It is a preventer, so it must be used every day. It does not relieve a sudden attack, and the US label says extra doses should not be used for that purpose.
Is 500 the right strength for me?
That is your doctor's decision. In the US label, 500/50 twice daily is the maximum asthma dose for people aged 12 and over, and 250/50 is the only approved COPD dose because 500/50 did not show an efficacy advantage. The UK and Australian labels use 50/500 for COPD in people with low lung function and repeated exacerbations. The UK label says to titrate to the lowest dose that controls symptoms. It is not suitable for children under 12.
What are the side effects of Seroflo 500 Ciphaler?
In the UK Seretide label, headache and nose and throat infections are very common, and thrush in the mouth and throat, hoarseness, throat irritation, low potassium, bruising, muscle cramps and, in COPD, pneumonia are common. In a 3-year US label trial in COPD, pneumonia was reported in 16% on 500/50 against 9% on placebo. Rare effects include adrenal suppression, slowed growth in children, lower bone density, glaucoma, heart rhythm problems and wheezing straight after a dose. Rinsing your mouth after each dose helps with thrush and hoarseness.
Who should not use Seroflo 500 Ciphaler?
Do not use it if you are allergic to salmeterol, fluticasone propionate or any ingredient, if you have a severe milk protein allergy (US label; the US product contains lactose, which contains milk proteins, and the Indian listings do not name the excipients), or as the main treatment for a severe attack. Do not use it with another LABA inhaler such as Foracort, and it is not suitable for children under 12. The US label says strong CYP3A4 inhibitors such as ritonavir, ketoconazole, itraconazole and clarithromycin are not recommended with it. Talk to a doctor first about heart disease, seizures, thyroid disease, diabetes, liver disease, pregnancy, or coming off steroid tablets; the US label says it should be used with caution, if at all, in people with active or quiescent tuberculosis of the respiratory tract.
Do I need a prescription for Seroflo 500 Ciphaler?
Yes. Salmeterol with fluticasone inhalers are prescription only in the US, the UK, Australia (Schedule 4) and Canada, and Indian listings (Tata 1mg, Medkart) mark Seroflo 500 Ciphaler as prescription required. This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada, and the FDA says personal importation of unapproved medicines is illegal in most circumstances. Check the rules where you live.
How long does delivery take?
Standard delivery takes 7 to 14 business days to the US, UK, Australia and Canada, in plain packaging with tracking. Shipping is a flat $25 on orders under $149 and free from $149. Order at least three weeks before your current inhaler runs out, because a preventer works only if it is used every day and the UK label warns against stopping it abruptly. Our parcels are not temperature controlled; the UK Sereflo Ciphaler label says do not refrigerate or freeze it.
Medical References
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Seroflo 500 Ciphaler? Tell other buyers how it went.







